Abortion
‘DIY’ abortions at home
The Covid-19 pandemic has caused untold loss, trauma and
upset. Such harms have been exacerbated by poor decisions,
lack of clear thinking and transparency at all levels –
personal, parliamentary and public. We have all suffered.
In its efforts to encourage people to stay at home and to
protect the NHS, the UK government approved emergency measures
to allow ‘pills-by-post’ and ‘DIY’ abortions. Since the
end of March 2020, these measures have allowed consultations
with a single doctor or nurse over the phone, after which, if
considered appropriate, both sets of abortion pills
(mifepristone and misoprostol) would be sent to the woman’s home
for her, in effect, to perform an abortion on herself up to 10
weeks of her pregnancy.
These new ‘DIY’ provisions are not in women’s best
interests. The procedure is not without complications –
some women suffer from this type of early medical abortion
(EMA). And any abortion away from a clinical environment
and in the absence of any medical professionals overseeing the
abortion process is likely to increase potential problems.
And there is the disposal of the dead embryo or foetus – an
unprecedented procedure for all women and perhaps traumatic for
many.
Now the focus has changed from arguments about granting
permission for these new ‘DIY’ measures to whether this
emergency provision, initially promised to be temporary for two
years, should be made permanent, even when the Covid-19 pandemic
is sufficiently over so that it is no longer the reason for the
original provision.
The various UK governments have published public consultations
on the matter. Once the deadlines have been reached, the
results will be awaited, as will be the subsequent actions by
politicians. Public consultations are a part of the
democratic process. However, when it comes to implementing
the public responses, especially on bioethical topics, the
records of action have not always been satisfactory.
Plan C abortions
If Plan A is straightforward abortion of a confirmed pregnancy
and Plan B is administration of the morning-after pill with its
abortifacient mode of action, what is Plan C? It is an
alleged new type of ‘contraception’ for women who do not want to
know if they are pregnant or not. Called the Missed Period
Pill (MPP), it is a uterine evacuation medication that induces
bleeding, similar to a menstrual period. It would
therefore terminate a pregnancy for nearly all pregnant women
users. Its USP (unique selling point) is that it fills the
gap between emergency ‘contraception’ and straightforward
abortion. Moreover, users would not know whether or not
they were pregnant. Hence, its advocates claim, it would
avoid the burden of that knowledge and take away any stigma or
shame associated with abortion. This is a ploy to
introduce moral ambiguity.
Here is the real surprise. Missed Period Pill is a
euphemism for abortifacient drugs or herbal concoctions.
In fact, it turns out that Plan C could be that old combination
of mifepristone, which blocks the effects of progesterone, the
hormone without which the lining of the uterus begins to break
down and thus prevents implantation and so the embryo or foetus
dies, while the second drug, misoprostol, causes the uterus to
contract and expel its contents, including the dead embryo or
foetus if present.
The promotion of Plan C might seem a little archaic and weird,
but at least it provided a research project for a team of women
investigators. They surveyed women’s interest in the MPP
across two US states. In all, of the 678 people surveyed,
42% indicated interest in MPPs. Interest was greatest
(70%) among those who would be unhappy if pregnant. In
other words, it would suit those who despite the ubiquity of
home pregnancy testing kits, they would prefer not to know.
These somewhat humdrum results were reported in the journal
Contraception under the title, ‘Exploring potential interest in
missed period pills in two US states’ by Wendy Sheldon et al.,
(2020, 102: 414-420). The authors concluded that,
‘If missed period pills were available in the United States,
demand might be substantial and wide-ranging across demographic
groups.’
But let’s not overlook the fact that the first author of the
study, Wendy Sheldon, is on the staff of Gynuity Health
Projects, the ‘reproductive and maternal health’ group that
partners with Planned Parenthood and other abortion providers
from which funding for the study in Contraception came.
In short, the results may be regarded as both unnerving and also
consoling. Unnerving, because some women do not apparently
want to listen to and understand their own bodies, whether they
are pregnant or not. Consoling, because some women are
still unsure about the moral conflicts and rightness of abortion
– it is not easily destigmatised. Perhaps, above all, the
work demonstrates that extreme abortion activists in the
reproductive rights movement are not entirely in tune with the
rest of the sisterhood – a significant sensitive and diffident
faction still exists.
Can abortion history be changed?
‘Pull down their statues’ is the modern cry. Architects of
slavery must be erased from the streets and the history
books. The names of various benefactors of universities
and other public buildings must be expunged. Their dark
histories will no longer be tolerated. History must be
changed, it must be purified, or at least airbrushed.
Support our cancel culture.
We all live and benefit from the exploits of both good and
wicked men and women. A selective view of a deleted
history serves no noble purpose. We must face the truth,
both rough and smooth. Unmanipulated history teaches us
valuable truths – read your Bible for explicit examples!
Try telling that to Planned Parenthood, the largest abortion
agency in the US and around the world. It has had to face
the link between its founder, Margaret Sanger, and the modern
eugenics movement. She campaigned for, ‘the gradual
suppression, elimination and eventual extinction, of defective
stocks – those human weeds which threaten the blooming of the
finest flowers of American civilization’ as she so indelicately
put it.
Then there is the very British Marie Stopes. Her name is
associated with the British charity with 12,000 employees which
claims to be ‘one of the world’s largest providers of high
quality, affordable contraception and safe abortion
services.’ Each year it helps around 5 million women
procure an abortion. It has clinics in 37 countries around
the world.
The problem is that Mrs Stopes, pioneer of birth control, was
also an ardent devotee of eugenics, advocate of compulsory
sterilisation, a devotee of eugenics, an enthusiast of social
Darwinism and admirer of Adolf Hitler. How to bury that
despicable history? Simple, in November 2020, they
expunged her by renaming Marie Stopes International as MSI
Reproductive Choices. It is called PR, public
relations. Problem solved. Except that renaming or
denaming is not the right way to address historical
wrongs. After all, does abortion now have neither
contemporary nor historic connections with eugenics? Hide
the truth and you fool yourself.
Down’s syndrome facts and figures
Since 2012, Down’s syndrome (DS) births is the UK have fallen by
54%. That is the year that controversial non-invasive
prenatal testing (NIPT) became available in the UK.
NIPT involves a blood test claimed to be 99% accurate for
detecting the condition as early as week 9 of a pregnancy.
Opponents of such testing have argued that it would inevitably
lead to more abortions, and a fear that Down’s children could be
eradicated altogether. Those fears are now being realised.
The relevant data are contained in a report, published in the European
Journal of Human Genetics (2020, 31 October) by de Graaf
et al., under the title, ‘Estimation of the number of people
with Down syndrome in Europe’. They are derived from
Europe-wide statistics from countries’ registries and databases
between 2011 and 2015. The figures show that in Southern
Europe, Down’s syndrome births fell by 71% due to
abortion. In Northern Europe, the number of births fell by
51% and by 38% in Eastern Europe.
The senior author of the study, Brian Skotko, said that the
findings would aid ‘deep discussions’ on how countries implement
NIPT and its ‘impact on the country’s Down’s syndrome
population’ and ‘supporting couples who receive a prenatal DS
diagnosis.’ Currently in the UK, approximately 92% of
those prenatally diagnosed with Down’s syndrome are aborted.
Poland and abortion
Tougher restrictions on abortion in Poland were introduced on 22
October 2020. The very next day thousands of protesters
took to the streets in Warsaw and other Polish cities to oppose
the ruling by the country’s Constitutional Court that banned
abortions for unborn children who have congenital defects.
A 1993 law allowing abortion in cases of severe and irreversible
foetal abnormalities was declared to be unconstitutional.
The Court’s judges voted 11 vs 2 in favour.
The Court’s president, Julia Przylebska, said that allowing
abortions in cases of foetal abnormality legalised, ‘eugenic
practices with regard to an unborn child, thus denying it the
respect and protection of human dignity.’ And because the
Polish Constitution guarantees a right to life, she added,
terminating a pregnancy based on the health of the foetus
amounted to ‘a directly forbidden form of discrimination.’
Poland is a predominantly Roman Catholic country and the
demonstrators’ rage has been directed at the Church – protesters
have disrupted Masses, verbally abused priests, defaced
buildings and vandalised memorials to Pope John Paul II.
At the same time, right-wing groups have responded by defending
churches and disrupting some demonstrations.
Poland already had one of Europe's most restrictive abortion
laws and the new ruling will result in a near-complete ban on
abortion. The only other legal sanctions for abortion are
for cases of rape or incest or if the pregnancy threatens the
woman's life or health. Almost all legal abortions in
Poland are performed on the grounds of foetal defects, so this
ruling, which is final and binding, effectively bans pregnancy
terminations.
In the middle of the fury was Poland's president, Andrzej
Duda. He initially supported the ban on abortion for
foetal abnormality, but now appears to have changed his
mind. Now he believes that women should have the right to
abortion in some cases though he still favours outlawing
abortion if a foetus has a non-lethal congenital defect.
Then after two weeks of demonstrations by hundreds of thousands
of Poles, who defied coronavirus restrictions, the right-wing
government drew back and delayed implementation of the new law –
the ruling remained unpublished and therefore it had no legal
power. Parliamentarians called for a time of
dialogue. President Andrzej Duda proposed new legislation
that would allow the abortion of foetuses with life-threatening
defects, but ban them for non-lethal disorders such as Down's
syndrome.
Then at the end of January 2021, the Polish government announced
that the new October-approved law would come into force from
midnight on Wednesday 27 January. Abortion is now allowed
only in cases of rape or incest or when the pregnancy threatens
the life of the mother.
The arguments remain polar opposites. One protestor,
Gabriela Stepniak said, ‘I want us to have our basic rights, the
right to decide about our bodies, the right to decide what we
want to do and if we want to bear children and in what
circumstances to have children.’ A defender of the unborn,
Karolina Pawlowska, declared, ‘We are very happy that this
judgement has been published. It is a great step towards
the realisation of human rights of all human beings. This
also means there will no longer be discrimination against
children who are sick or disabled.’
Argentina and abortion
The homeland of Pope Francis has legalised abortion. It
happened on 30 December 2020, when the Argentine Senate voted to
decriminalise abortion in the first 14 weeks of pregnancy.
The voting was 38 vs 29 with 1 abstention.
In other words, abortion will be allowed in the first trimester
for any or no reason. Thereafter, it will be allowed if
the pregnancy is the result of a rape, or if the mental health
of the mother is at risk.
Argentina’s legal change may create a domino effect on abortion
access in South and Central America. Abortion is already
legal in Uruguay, Guyana, and Cuba, as well as parts of Mexico,
but in El Salvador, the Dominican Republic, Nicaragua, and
Honduras abortions remain illegal.
And conscientious objection may become problematic in Argentina,
where many Roman Catholic doctors are likely to refuse abortion
requests. Under the new law, doctors are legally bound to
either perform an abortion, or, if they are conscientious
objectors, they must immediately refer the woman to a compliant
doctor.
According to recent polls, less than 30% of Argentinians
supported this legalisation of abortion on request. After
the Senate announcement, Karina Marolla, a 49-year-old opponent
of the new law, said, ‘What was voted for today is the death
penalty for the most innocent. Today in Argentina there’s
no law giving the death penalty to rapists or murderers.
So we’re feeling sad, to put it lightly.’
IVF and
ARTs
The
14-day rule
‘For the past 40 years, the 14-day rule has governed and, by
defining a clear boundary, enabled embryo research and the
clinical benefits derived from this. It has been both a
piece of legislation and a rule of good practice
globally.’ That is how Sophia McCully opened her article
entitled, ‘The time has come to extend the 14-day rule’ in the Journal
of Medical Ethics published online on
2 February 2021. She continues, ‘In this paper, I argue
that the current limit for embryo research in vitro should be
extended to 28 days to permit research that will illuminate
our beginnings as well as provide new therapeutic
possibilities to reduce miscarriage and developmental
abnormalities.’
None of this is new. Since 1984, when the Warnock
Committee cobbled together some arbitrary and specious
arguments to recommend limiting human embryo research and
destruction to an upper limit of 14 days, scientists have
complained that it is too restrictive. On the other
hand, many said it was too liberal. Eventually, the
14-day rule became part of the 1990 Human Fertilisation and
Embryology Act. Now, as part of their case for extending
the limit, proponents are even claiming that Warnock’s
arguments were random and spurious. Well I never!
The current calls for change centre on scientists’ probable
ability to culture human embryos beyond 14 days – a sort of
‘if we can, why not?’ reasoning. The popular bid is now
for 28 days – just as arbitrary and compromising as Warnock’s
original. But the hook is, 28 days would ‘permit
research that will further explore our origins as well as
potentially provide new therapeutic possibilities to reduce
developmental abnormalities and miscarriage’ as McCully has
written elsewhere In other words, it would allow
exploration of the so-called ‘black box’ period of human
development.
Will just one slice of pizza satisfy the hungry
teenager? And so how long will 28 days satisfy?
This is where robust bioethics should be at its best.
Everyone knows that life is not a free for all – boundaries
are needed for people and civilisations to thrive. Just
as the limit of 24 weeks is not enough for abortionists, and
transferring just two embryos is not enough for IVF
practitioners, so 28 days would ultimately become
inadequate. If the deliberate destruction of human life
is to be avoided, then abortion and embryo experimentation
should be illicit. The boundary should not be 14 or 28
days, it should be zero.
Expect a UK government consultation on the issue in 5 years’
time, maybe sooner.
A 27-year-old embryo is born
Mess with biology and that is the sort of strapline you
get. Molly Gibson was conceived in 1992, transferred to
a womb in February 2020 and born in October 2020.
Accordingly, she has set a new world record for the
longest-frozen embryo to result in a live birth.
Tina and Ben Gibson of Knoxville, Tennessee, struggled with
infertility for nearly five years. They approached the
National Embryo Donation Center (NEDC) in Knoxville. The
NEDC is a Christian, non-profit organisation that stores
‘spare’ frozen embryos donated by IVF patients.
Families, like the Gibsons, can then 'adopt' a stored embryo
and use IVF to maybe give birth to a child that is not
genetically related to them. Both Molly's and her sister
Emma's embryos were donated by the same couple and frozen
simultaneously. Emma was born in 2017 and had held the
previous record for 24 years as a frozen embryo.
After the whoops of delight caused by Molly’s birth had
subsided, a serious issue arose. Currently, the UK has a
ten-year storage limit for frozen human gametes and embryos as
defined by the 2008 Human Fertilisation and Embryology
Act. At the end of the storage period, the woman must
decide whether to become a mother, or have her ova and/or
embryos destroyed. An extension can only be granted for
medical reasons and premature infertility.
Molly’s birth in the USA has sparked calls for this time limit
to be scrapped in the UK. Sarah Norcross of Progress
Educational Trust commented, ‘It's time for the Government to
change this arbitrary law which damages women's chances of
becoming biological mothers and limits their reproductive
choices.' That’s all very highfalutin jargon, but IVF is
a bioethical and practical ‘can of worms’ and its legal
boundaries are there for a reason.
The NEDC is one of several embryo adoption agencies in the
USA. Like others it has a strong Christian ethos – its
website states, ‘The NEDC firmly believes in the sanctity of
life beginning at conception and recognizes marriage as a
sacred union between man and woman as defined by scriptures of
the Holy Bible.’ Since its inception in 2003, NEDC has
assisted in over 1,000 births and received more than US$3.9
million in federal funding. But the concept and practice
of embryo adoption poses thorny bioethical problems. For
more details, read Chapter 3 and especially pages 94-95 of my
2014 Bioethical Issues book.
IVF children and cancer
This is a recurring theme. Children conceived by IVF
have a higher risk of developing cancer than those conceived
naturally. This fact has been reconfirmed recently by a
team of scientists and statisticians from across America and
published as, ‘Assessment of Birth Defects and Cancer Risk in
Children Conceived via In Vitro Fertilization in the US’ by
Luke et al., in JAMA
Network Open (2020, 29 October).
The researchers used birth data from Massachusetts, New York,
Texas and North Carolina recorded between 2004 and 2016.
They cross-referenced these with various birth defect and
cancer registries. They considered only IVF babies
conceived with their parents' gametes, excluding frozen
gametes, to get as close as possible to the conditions used by
the natural conception cohort. In all, the study covered
1,000,639 children born to fertile women and 52,776 children
conceived via IVF.
The authors stated that, ‘The increased risk was 2-fold higher
for children conceived via in vitro fertilization than for
children conceived naturally.’ But as ever in these
sorts of studies the authors raise the key issue as, ‘An
unresolved question in assisted reproduction research remains
the contribution of parental versus treatment factors to
adverse outcomes.’ In short, do the cancers arise from
the parents, or the IVF procedures, or both, or neither?
Among the notable differences between the two groups were 1.8%
of babies conceived naturally had congenital malformations,
compared with 2.4% in the group of babies conceived by
IVF. And all babies with non-chromosomal abnormalities
had a higher risk of cancer. The risk was multiplied by
2.07 for babies conceived naturally and by 4.04 for IVF
babies. There is food for further thought and
investigation here.
IVF and the stupid
Paris Hilton, the 39-year-old American heiress, media
personality, businesswoman, socialite, model, singer, actress
and DJ, wants a baby or two. More precisely, she wants a
boy and a girl. So, as recommended by the famous Kim
Kardashian, she is undergoing IVF treatment with her
boyfriend, Carter Reum.
She wants to start the process now to ensure she could have
‘twins that are a boy and a girl’ since parents can, for an
added cost, sex select which embryos they want to use.
‘I think it's something most women should do just to have and
then you can pick if you want boys or girls’, Ms Hilton added
somewhat dimwittedly, and ‘The only way to 100% have that is
by doing it that way.’
Apparently, many felt Hilton's comments were ‘out of touch’
and insensitive to people struggling with infertility who
cannot afford IVF, a procedure that can cost upwards of
$12,000. A celebrity website, Insider,
commented on some ethical problems associated with choosing
the sex of IVF children. And, ‘In addition to being an
expensive procedure many people in the US can't afford, the
idea of ‘picking’ a child's gender before they are born may
present some problems. Since a child could be
transgender, and may not identify with the gender they are
assigned at birth, no one truly knows what gender their child
will be.’
If Paris Hilton thinks that IVF plus PGD (preimplantation
genetic diagnosis) will fulfil her baby dreams, she has yet to
face some harsh realities. Sometimes I feel I don’t
belong in this world.
Euthanasia and Assisted Suicide
Canada goes for broke
Here is a bioethical truth – open a permissive door a little
and soon it will swing wide open. Here is proof from
Canada. In June 2016, the Parliament of Canada passed
federal legislation that allowed eligible Canadian adults to
request ‘medical assistance in dying’ (MAiD). On 5
October 2020, the Minister of Justice and Attorney General of
Canada introduced Bill C-7 with proposals for a major
expansion of the country’s 2016 euthanasia laws. Critics
say that the amendments will make Canada’s law the most
permissive in the world.
Bill C-7 would give access to MAiD to people whose natural
death is not reasonably foreseeable. It would also
establish more relaxed eligibility rules for those who are
near death, including a form of advance directives.
Critics insist that C-7 will change MAiD ‘from a procedure to
facilitate dying into a terminal therapy for life’s
suffering.’ In particular, the Bill would do away with a
doctor’s traditional ‘standard of care’, which obliges
‘physicians to apply their skills and intricate knowledge to a
patient’s particular clinical circumstances.’ Instead
patient choice, effectively self-diagnosis, of ‘enduring and
intolerable suffering’ would become the criterion for deciding
whether or not he or she is eligible for MAiD and the
prescription of the remedy, death.
It gets worse. On 17 February 2021, Senators
overwhelmingly approved a revised version of Bill C-7 by a
vote of 66-19, with three abstentions. In addition,
Senators approved five amendments, two of which would expand
access even more than the government proposed. One
amendment would allow people who fear losing mental capacity
to make advance requests for assisted death. The other
would impose an 18-month time limit on the Bill's proposed
blanket ban on assisted dying for people suffering solely from
mental illnesses. The revised Bill will now be sent back
to the House of Commons for MPs to decide whether to accept or
reject some or all of the amendments. The government
wants the Bill passed by 26 February.
Parliamentary critics have expressed alarm at the haste with
which the Canadian law is changing. But that is what
happens with bad laws – they become slippery slopes.
Consider the figures from Ontario, Canada’s largest
province. In 2020, there were 2,378 cases of MAiD, up
from 1,789 the previous year, 1,499 in 2018, 841 in 2017 and
189 in 2016. Is that not a slippery slope?
And Spain
Spain is set to become the sixth country in the world to
legalise euthanasia. After decades of social debate and
four previous failed attempts, a euthanasia Bill has been
passed with cross party support from leftist and conservative
parliamentarians. The vote on 17 December 2020 by the
Congress of Deputies, the nation’s lower house of parliament,
passed by 198 votes to 138 with two abstentions. If the
Bill gets its expected approval in the Senate, it could be
passed into law as early as spring 2021.
The new law is designed to allow the patient to decide between
euthanasia, performed by a healthcare professional, or
assisted suicide, which could take place at home by taking a
fatal dose of prescribed medication.
Under the proposed legislation, public and private healthcare
professionals will be able to assist patients who no longer
wish to suffer ‘a serious and incurable disease’, or a
‘debilitating and chronic condition’ that is
‘unbearable.’ They would also need to be Spanish
citizens or residents, over the age of 18, who can make
rational decisions, and who have asked to die on four
different occasions during the process, which must be no less
than a month. The first two requests must be written and
submitted two weeks apart, while the third must come after
consulting a doctor.
New Zealand legalises euthanasia
The latest jurisdiction to legalise euthanasia is New
Zealand. In 2019, the New Zealand Parliament had passed
an End of Life Choice Act, which included criteria, such as
the patient must be 18 or over, a New Zealand citizen,
suffering from a terminal illness that will end their life
within six months, ‘have a significant and ongoing decline in
physical capability’, ‘enduring unbearable suffering that
cannot be eased’ and in a position to make an ‘informed
decision’ about their death.
But the Act had to be ratified by a national referendum – the
first time anywhere that the issue has been settled this
way. It appeared as an additional question on the 17
October general election ballot paper. It simply read,
‘Do you support the End of Life Choice Act 2019 coming into
force?’
The final results showed that 65.1% of people supported the
Act while 33.7% were opposed. Because the referendum
result is binding, the law is expected to come into effect on
6 November 2021, one year after the final results were
announced.
Lockdown and Dignitas
Recently, the various countries of the UK have entered into
various Covid-19 lockdowns. Under the banner of ’Stay at
Home’, travellers have only been exempted for the purposes of
work, education, or other legally-permitted reasons.
Certainly, holiday travel overseas has been banned.
Yet there was another exemption, another ‘reasonable excuse’
as Matt Hancock, Secretary of State for Health and Social Care
told Parliament on 5 November. He explained, ‘The new
coronavirus regulations which come into force today place
restrictions on leaving the home without a reasonable
excuse. Travelling abroad for the purpose of assisted
dying is a reasonable excuse, and so anyone doing so would not
be breaking the law. The question of how we best support
people in their choices at the end of their life is a complex
moral issue that, when considered, weighs heavily upon us
all.’
In other words, you cannot travel to hug your grandchildren,
or visit your lonely mother, but you can travel abroad to
Dignitas, or any other such ‘clinic’, to have your life
deliberately ended. Is that not a little odd?
Palliative care provision
Oh, for something life-affirming and positive! Here it
is. The Covid-19 pandemic has stretched the UK’s
provision of palliative care. According to researchers
from Cicely Saunders International, the predicted capacity of
about 0.5 million people in England and Wales needing such
care by 2040 has already been reached.
Their 2020 Report, which makes an urgent call for reforms to
the UK’s palliative care system, is entitled, You
matter because you are you: an action plan for better
palliative care. It asserts that too many people
who had life-limiting illnesses, or were approaching death,
were spending unnecessarily long periods in hospital without
being offered alternatives, when most would prefer to die at
home. Around 80% of people would prefer to die at home,
or in their place of residence, but in some parts of England
and Wales less than 50% do so.
To help meet people’s needs the
authors call for face-to-face care, including symptom
management, seven days a week access to hospitals, as well as
24/7 support and advice in the community. Prompt access
to therapeutic, nursing, and pharmacy services to support
people in their homes are also needed. Other
recommendations in the Report’s seven-point action plan
include increased investment in social and community care
services, a strategic approach to training, and a system of
continuous learning and improvement. And it draws
attention to a government-commissioned review, which estimated
that £150m is needed to provide a ‘national choice offer’ to
patients and carers for end-of-life care.
Irene Higginson, scientific director at Cicely Saunders
International, commented, ‘The Covid-19 pandemic has made it
clear that, when the demand for health and social care
services goes up, the provision of palliative care falls
short. It’s vital that we learn from this experience and
implement the changes necessary to secure high quality
palliative care for all patients.’
And Kathryn Mannix, a palliative care physician, said, ‘Access
to support for wellbeing, person-centred care, and excellent
symptom management should be seen as a human right throughout
life. It is time to recognise that people approaching
death have the same rights and to fund the services that will
allow them to live well for the remainder of their
lives.’ Could all that not be a positive outcome from
the Covid-19 pandemic?
Genetic Technologies
Anti-CRISPRs
In the last decade, the world of experimental biology has been
transformed by the discovery and application of the CRISPR-Cas
gene-editing procedure. Simply by changing a little of
an organism’s genetic code, it has been successfully applied
to curing human diseases as well as improving crops and
livestock.
But sometimes a good thing needs controlling, even
stopping. What if gene-editing cannot be halted, could
it have disastrous consequences? What we need is an
off-switch, an anti-CRISPR mechanism. And several have
recently been discovered.
When bacteria are invaded by viruses the latter are
susceptible to the bacterial CRISPR-Cas defence system.
But sometimes the invading viruses survived. How
come? It turns out that viral genes were somehow capable
of shutting down the CRISPR-Cas system so the bacteria became
susceptible. Anti-CRISPRs were realised. Now more
than 50 anti-CRISPR proteins have been characterised.
Scientists now have a toolkit for keeping gene-editing in
check. But it is early days. As Jennifer Doudna,
one of the pioneers of CRISPR gene-editing, has asked, ‘How do
you actually use these in a way that will provide meaningful
control?’
Here is one such example of progress. In 2017,
biologists at the Harbin Institute of Technology in China
deciphered the molecular mechanism by which one anti-CRISPR
protein, called AcrIIA4, can shut off Cas9 activity. A
few months later, Doudna and colleagues, demonstrated that
anti-CRISPRs have practical value. They showed that
delivering AcrIIA4 into human cells could not only halt
gene-editing activity, but also limit those dreaded
‘off-target’ effects of gene-editing. That was back in
2017. [Dong et al., Nature,
2017, 546: 436–439. Shin et
al., Science Advances, 2017, 12
July].
Two years later in 2019, a US team, led by Erik Sontheimer, at
the RNA Therapeutics Institute, University of Massachusetts
Medical School, demonstrated that the approach can work in
mice – so far the only demonstration that anti-CRISPR proteins
can work in a living animal, and not just cells.
Sontheimer and his colleagues wanted to allow editing in the
liver while suppressing it in all other tissues of the
mouse. So they designed an anti-CRISPR protein that
would be active everywhere except in the presence of
microRNA-122, which is found only in the liver. In the
mice, the anti-CRISPR successfully blocked Cas9 editing
throughout the body, except in that one organ. [Lee et
al., RNA, 2019, 25:
1421-1431].
This is remarkable, even exciting, progress. CRISPR-Cas9
and the other techniques of gene-editing have proved to be
revolutionary. Now to have a start-stop control
mechanism of the system is phenomenal. Biology will
never be the same.
Gene therapy for eyes
Leber hereditary optic neuropathy (LHON) is a rare inherited
form of vision loss which generally affects young men.
Its first symptoms are typically a sudden but painless
blurring and clouding of sight. If vision loss starts in
one eye, the other eye is usually affected within several
weeks or months. Most sufferers are severely impaired
after 3 or 4 months.
Gene therapy, using adeno-associated viral (AAV) vectors, has
been a promising strategy for treatment of various eye
diseases. LHON is caused by a mutation in the eye’s
mitochondrial DNA (mtDNA). This in turn destroys cells
of the retina, the tissue at the back of the eye that turns
light into electrical signals. A recombinant AAV,
rAAV2/2-ND4, has been therapeutically effective in a mouse
model of LHON.
In a phase 3 clinical human trial, 37 LHON patients were given
either a single injection of rAAV2/2-ND4 or a sham injection
in their right eye. The left eye received the treatment not
allocated to the right eye. Unexpectedly, sustained
visual improvement was observed in both eyes over the 96-week
follow-up period. A total of 25 subjects had a
clinically relevant recovery in best-corrected visual acuity
(BCVA) in at least one eye, and 29 subjects had an improvement
in vision in both eyes, even in the sham-treated eyes.
How had visual improvement occurred in both eyes? The
team conducted a primate study of the therapy in three macaque
monkeys. They found evidence of transfer of the viral
vector DNA from the injected eye to the anterior segment,
retina and optic nerve of the non-injected eye. These
findings suggest that the virus used the optic nerves to
travel between the treated and untreated eyes.
However, the phase 3 experimental design was faulty. The
original strategy was to compare vision in the treated eye
against that in the untreated eye. This was not possible
in this trial because the untreated eye may also have received
the therapy. Future trials are needed to compare people
given the gene therapy with others who receive a placebo.
This study was published as ‘Bilateral visual improvement with
unilateral gene therapy injection for Leber hereditary optic
neuropathy’ in Science Translational
Medicine (9 Dec 2020) by Patrick
Yu-Wai-Man et al.
More gene therapy for more eyes
Several common eye diseases damage the retina, the
light-sensitive tissue in the back of the eye.
Age-related macular degeneration and retinitis pigmentosa are
among these diseases that damage photoreceptors, leading to
vision loss. There are currently no cures for these
diseases, though a gene therapy that could restore the fading
sight of the elderly is being tested in humans for the first
time after positive results were obtained in blind mice.
The team from Nanoscope Technologies of Bedford, Texas has
modelled and synthesised a gene that produces a more
photosensitive form of opsin. Opsins are the
light-sensitive proteins that can convert photons of light
into electrochemical signals. This MCO1 opsin gene was
then tested in mice that were completely blind from retinal
degeneration. The gene was added to a harmless virus and
injected into the animals’ eyes. This one-time injection
therapy restored retinal function and vision to the blind
mice. Post-treatment these mice were significantly
faster in standardized visual tests, such as navigating mazes
and detecting changes in motion.
Human trials of the treatment have begun in India and are
expected to start in the United States soon. Team
leader, Subrata Batabyal, has said that, ‘A clinical study in
people will help us understand how signalling through bipolar
cells affects vision quality; for example, how well treated
eyes can pick out fast-moving objects.’
This work entitled, ‘Sensitization of ON-bipolar cells with
ambient light activatable multi-characteristic opsin rescues
vision in mice’ by Bababyal et al.,
was published online in Nature Gene
Therapy (2020, 22 October).
Brains in a dish
Where are the bioethical boundaries of human genetic
technologies? We already have genetically-engineered
babies, three-parent human embryos and novel family
combinations. Now consider this – human brains in a
dish, created from stem cells.
Not only is that physical prospect unnerving, but could these
clumps of cells, these disembodied brain organoids, become
conscious? Electrical activity in these structures has
already been reported. A review article by Sara Reardon
in Nature (2020, 27
October) entitled, ‘Can lab-grown brains become conscious?’
included this statement, ‘The studies have set the stage for a
debate between those who want to avoid the creation of
consciousness and those who see complex organoids as a means
to study devastating human diseases. [Alysson] Muotri
and many other neuroscientists think that human brain
organoids could be the key to understanding uniquely human
conditions such as autism and schizophrenia, which are
impossible to study in detail in mouse models. To
achieve this goal, Muotri says, he and others might need to
deliberately create consciousness.’
Where are the boundaries? So far, they have been little
more than voluntary guidelines. And, after all, what is
unethical – what does that mean? It is easy to be
soothed by talk of ‘essential research’ and prospects of
overcoming serious diseases. Should we not be appalled
by these trends? Is human dignity at stake?
Alysson Muotri, a world leader in this field at the University
of California, San Diego, remains indifferent. As
Reardon states, ‘For his part, Muotri sees little difference
between working on a human organoid or a lab mouse. “We
work with animal models that are conscious and there are no
problems,” he says. “We need to move forward and if it
turns out they become conscious, to be honest I don’t see it
as a big deal.”’
Not everything about genetic technology is wonderful.
Stem-cell Technologies
California Institute for Regenerative
Medicine (CIRM)
The election of the President of the United States was not the
only question on recent US ballot papers – in California on 3
November, Proposition 14, the Stem Cell Research Institute
Bond Initiative (Prop 14), was on the ticket too. This
ballot initiative would allow CIRM to borrow US$5.5 billion in
the form of bonds. Californian taxpayers would have to
repay this sum with interest over the next 30 years.
Prop 14 divided the residents of the Sunshine State, but on
the day it sneaked passed by 51% to 49%.
CIRM was opened in 2004 with typical West Coast zest and zeal
and with an allocation of $3 billion funding. It was
controversial for many reasons including its major intent of
destroying human embryos to create embryonic stem cells.
But its record has been mixed. True, CIRM research has
led to two approved cancer drugs and a host of prospective
therapies, but the promised ground-breaking stem-cell cures
and therapies have been wanting. More than half the
original funding went on buildings and other infrastructure,
education and training.
By 2019 the CIRM was running out of money and it suspended
applications for new research projects. It had also been
dogged by a string of political and bureaucratic
wrangles. Nowadays California is suffering from huge
budget deficits, a largely uncontrolled Covid-19 pandemic as
well as housing and unemployment crises. This time round
taxpayers, investors and scientists will be keen to see some
solid returns from their US$5.5 billion venture. If CIRM
still insists on funding major embryonic and fetal stem-cell
research projects, they will probably be very
disappointed. Adult stem-cell therapeutics have already
won the day.
Stem-cell organoids and Covid-19
The virus that causes Covid-19 infection, SARS-CoV-2, attacks
primarily the lungs. Two teams of scientists have
recently reported the successful growth of 3-D lung models in
order to study the progression of Covid-19. The models,
called organoids, act like ‘mini-lungs’ and may also be used
to screen potential therapies for treating Covid-19 cases.
The teams from the Wellcome-MRC Cambridge Stem Cell Institute
and Duke University in Durham, North Carolina, independently
reached the same conclusions. Their studies relied on a
technique for isolating specific stem cells called AT2s, or
alveolar type 2 cells, from healthy human lung alveoli.
These AT2s were grown into 3-D organoids and then infected
with SARS-CoV-2.
Shortly after infection, these AT2
cells began producing interferons, molecules that create
distress signals to the immune system. After 60 hours of
infection the lung cells began to die, resulting in tissue
damage.
Genetic comparisons between infected organoids and lung tissue
from Covid-19 patients showed them to be similar. In
short, these stem-cell organoids appear to be a reliable model
for studying SARS-CoV-2 infection with wide-reaching
implications for Covid-19 research and treatments.
Senior author of the Duke University study, Purushothama Rao
Tata, considered the potential of the 3-D model goes beyond
Covid-19 research. He has stated, 'This is a versatile
model system that allows us to study not only SARS-CoV-2, but
any respiratory virus that targets these cells, including
influenza.' Some of this work has been described by
Katsura et al., as 'Human lung stem cell-based
alveolospheres provide insights into SARS-CoV-2 mediated
interferon responses and pneumocyte dysfunction, in Cell
Stem Cell (2020, 21 October).
A drug to improve stem-cell
treatments
Scientists at the Sanford Burnham Presby Medical Discovery
Institute, La Jolla, California have created a drug that could
improve current stem-cell therapies designed to treat
neurological disorders, such as spinal cord injury, stroke and
other neurodegenerative disorders as well as heart disease or
arthritis. It could represent a major advance in the
field of regenerative medicine.
One of the outstanding issues in stem-cell treatments is how
to direct the cells to the damaged tissue. Stem cells
are naturally drawn to inflammation, a biological ‘fire alarm’
that signals damage has occurred. However, using
inflammation as a lure for stem cells is not a sensible
strategy because an inflammatory environment can be harmful to
the body.
In the present study, the scientists modified CXCL12 – an
inflammatory molecule – to create a drug called SDV1a, a
peptide chemoattractant. This new drug works by
enhancing stem-cell binding and minimizing inflammatory
signalling. It can be injected anywhere to lure stem
cells to a specific location without causing inflammation.
To demonstrate that the new drug is able to improve the
efficacy of a stem-cell treatment, the team implanted SDV1a
and human neural stem cells, derived from human induced
pluripotent stem cells (hiPSC), into the brains of mice with a
neurodegenerative disease called Sandhoff disease. They
showed that SDV1a helped the human neural stem cells to
migrate and perform healing functions, which included
extending lifespan, delaying symptom onset, and preserving
motor function for much longer than the mice that did not
receive the drug. Importantly, inflammation was not
activated, and the stem cells were able to suppress any
pre-existing inflammation. Current work is investigating
the ability of SDV1a to improve stem-cell therapy in a mouse
model of ALS, also known motor neurone disease (MND).
The original findings have been published as ‘Chemical
mutagenesis of a GPCR ligand: Detoxifying
“inflammo-attraction” to direct therapeutic stem cell
migration’ by Jean-Pyo Lee et al., in
the Proceedings of the National Academy
of Sciences (2020, 117:
31177-31188).
BitBio
Stem cells are biological wonders, capable of becoming any of
the body’s 120 or so types of adult cells. But they are
often uncontrollable rascals. Now a British company,
Bit.Bio, has announced a procedure that it claims can more
reliably reprogramme stem cells, producing a ‘cellular vending
machine’ to make any human cell required.
Mark Kotter, the Cambridge neurosurgeon, who founded the
company, and incidentally the co-founder of the cultured meat
start-up called Meatable, has said,
that if successful it will mean, ‘you can turn cells into
computers where you can just invoke a new programme and force
them to take up a new identity. That’s a huge paradigm
shift.’
According to a report in The Times (2020,
27 October), the technology, which is already being applied
for more than ten cell types, could be used for better drug
discovery, therapies based on human cells, and eventually, in
building organs directly from the cells of a person needing a
transplant. But the idea that living cells can be
permanently programmed in this way, as if DNA is merely a
computer language, remains controversial in biology circles.
Conventionally, scientists have tried to reverse engineer this
process, by recreating the environment seen by stem cells
during their development into the target cells. This is
a laborious process. Another approach is to activate the
transcription factors that identify the target cell type, for
instance using viruses. The problem is that cells
typically fight back by ‘gene silencing’ the newly-activated
genes.
BitBio’s technology embeds these transcription-factor
programmes into specialised areas of the genome, which seems
to circumvent this ‘gene silencing’. Then using
machine-learning technologies and rapid cell screening, the
transcription factors to make different cells can be
identified. BitBio has now entered into a commercial
partnership with a non-profit research institution, the London
Institute of Mathematical Sciences (LIMS). Their
approach is a fusion of biology and mathematics for the
reprogramming of human cells.
Is this the power to make human cells to order and therefore
take regenerative medicine to a new level? Let’s not get
too excited, too soon.
Miscellaneous
Updating
the Hippocratic Oath
It was the Hippocratic Oath together with the Judaeo-Christian
doctrines that created wholesome human medicine and guarded it
for over 2,000 years.
The Oath has often been tinkered with and inevitably watered
down. Some examples are given on pages 24-25 of my 2014
book, Bioethical Issues. Now comes the newest revision
from first-year medical students at the University of
Pittsburgh School of Medicine. It is a thin affair.
The traditional Oath is concerned with the big and bold topics
of bioethics, such as abortion, conscience, euthanasia,
confidentiality and sexual abuse. This new version
instead champions diversity in medicine and society, being a
friend to the poor and marginalised, and restoring trust in
the healthcare community.
Here are extracts from the new and the old. Can you
guess which is which? ‘I will be an ally to those of low
socioeconomic status, the BIPOC community, the LGBTQIA+
community, womxn/women, differently-abled individuals and
other underserved groups in order to dismantle the systemic
racism and prejudice that medical professionals and society
have perpetuated.’ And ‘I will neither give a deadly
drug to anybody who asked for it, nor will I make a suggestion
to this effect. Similarly I will not give to a woman an
abortive remedy. In purity and holiness I will guard my
life and my art.’
Thankfully, the medical students took the traditional Oath as
well as their new-fangled rendering. Such novelties as
students creating their own versions suggest that medical
ethics and medical practice are flimsy, fashionable issues
rather than those built on robust, historic foundations.
Bioethics and the Covid-19 pandemic
In February 2020, the World Health Organization (WHO) arranged
a meeting in Geneva to discuss the pandemic. During the
two-day gathering, some ethical principles were
considered. These were published under the title, ‘Key
Ethical Concepts and Their Application to COVID-19 Research’
by Dawson et al., in Public
Health Ethics, 2020, 13:
127-132.
Bioethical principles are typically summarised under four
headings, namely, autonomy, beneficence, non-maleficence and
justice, as devised by Tom Beauchamp and James Childress in
their famous 1985 textbook, Principles of Biomedical
Ethics. The new Genevan principles are quite
different, moving away from autonomy towards community and the
common good. Here, according to Michael Cook of BioEdge,
is a summary of the new six:
Solidarity. ‘The practice of
standing up together and acting in common.’ ‘Just as
infection spreads through connection, our ethical response
requires us to act together to ensure recognition of our
common nature, needs and value.’
Equal Moral Respect. ‘There can be no room for
disagreement regarding the equal moral respect that is owed to
every individual. In short, equal moral respect serves
as a fundamental precondition for fair and equitable
treatment.’
Equity. ‘Treating people
equitably means treating like cases alike, e.g. treating
people in accordance with their unique needs.’
Autonomy. ‘An autonomous individual is able to
control what happens to their bodies and lives.
Autonomous people may also forego making choices.’
Vulnerability. ‘Its core
ethical function is to mark out the need for additional
ethical consideration, or heightened ethical scrutiny in the
context of research towards the risks and threats faced by a
person or group regarded as potentially vulnerable.’
Trust. ‘During public health
emergencies, such as COVID-19, action is required to ensure
the maintenance of trustworthiness in those given
responsibility for the response.’
James Randi (1928 – 2020)
I like a sceptic. After all, Christians are warned, ‘Do
not be deceived’ (1 Corinthians 6: 9), and 1 Thessalonians 5:
21 rings out, ‘Test everything. Hold on to the good’ and
similar directives elsewhere in Scripture. Moreover,
scientists are typically sceptical – they can spend a lifetime
trying to disprove a null hypothesis. So it was with the
illusionist James Randi, who devoted much of his career to
debunking frauds and pseudoscientific claims, which he called
‘woo-woo’. He spent a lifetime confronting superstition
and magical thinking with science and rationality.
He had two world-famous confrontations. The first
occurred in 1988 when the then-editor of Nature,
John Maddox, asked Randi to investigate a claim by the French
immunologist, Jacques Benveniste, who professed to have found
recurrent biological activity in a solution of antibodies
diluted well past the point at which any active ingredient
should remain. This alleged ‘memory of water’, published
in Nature in 1988,
seemed to offer support for homeopathy. Randi, Maddox
and Walter Stewart, a specialist in scientific misconduct,
went to Benveniste’s laboratory near Paris to witness a repeat
of the experiments. Benveniste was unable to replicate
his original findings, though he refused to retract his
controversial Nature article.
Randi’s second celebrated confrontation was with the
British-Israeli illusionist and self-styled psychic, Uri
Geller. A regular on TV during the 1970s, Geller would
demonstrate his skills memorably by his ‘psychokinetic’
spoon-bending. The two men became something of a double
act – Randi exposed Geller’s deceptions in his 1975 book The
Magic of Uri Geller, while Geller regarded their
sparring as good publicity.
Randall James Hamilton Zwinge was born in Toronto in 1928, the
son of Marie Alice (née Paradis) and George Randall
Zwinge. He was a precociously gifted child and he soon
developed an enthusiasm for magic. In his teens he
dropped out of school and actually ran away to join the
circus, or at least, a carnival roadshow, as a stage magician,
‘mind reader’ and escapologist. He was an unapologetic
showman. He posed as a mentalist in local nightclubs and
as an astrologer in a Canadian tabloid. In the 1970s,
James ‘The Amazing’ Randi spent time touring with the
theatrical rock star Alice Cooper, whom he ‘executed’ at the
end of each show. In 1976 he appeared in a Canadian TV
special when he escaped from a straitjacket while suspended
upside-down over Niagara Falls. When accused of being a
fraud, Randi replied, ‘Yes, indeed, I'm a trickster, I'm a
cheat, I'm a charlatan, that's what I do for a living.
Everything I've done here was by trickery.’ Randi always
denied having any psychic power, though not everyone believed
him.
For much of his life, he played the sceptic, the gentle
debunker, rather than the dark destroyer. With his
trademark wizard-style hats and sage-like beard, Randi
followed in the tradition, so popular in the nineteenth
century, that stage magic can be used to expose superstition
and psychic fraud. Thus he challenged faith-healers,
psychics and believers in UFOs. From the 1960s, he had
offered substantial sums of cash to anyone who could
demonstrate paranormal or psychic powers. From 1996,
until the prize was terminated in 2015, the James Randi
Educational Foundation raised the stakes to US$1
million. He had no takers.
In 1976, he joined with mathematician Martin Gardner,
planetary scientist Carl Sagan and science-fiction author
Isaac Asimov to found the Committee for Skeptical
Inquiry. The organisation still publishes the Skeptical
Inquirer, a magazine devoted to the scientific
investigation of the paranormal and other such extraordinary
claims.
James Randi was a lifelong atheist. He wrote that,
compared to the Bible, ‘The Wizard of Oz is
more believable. And much more fun.’ He also
wrote, ‘I've said it before: there are two sorts of
atheists. One sort claims that there is no deity, the
other claims that there is no evidence that proves the
existence of a deity; I belong to the latter group, because if
I were to claim that no god exists, I would have to produce
evidence to establish that claim, and I cannot.’
I do not recall that Randi directed his charm and brain to
matters bioethical. Nevertheless, there are still many
thespians in science and medicine, always ready to tell half a
story with overegged claims. And there are still crowds
who are credulous, be they anti-vaxxers, believers in sham
stem-cell treatments, conspiracy theorists, con artists, snake
oil sellers, falsifiers, fabricators and modifiers of data, or
just plain deceivers. And who does not want counterfeit
Christians with their pseudo-religious claims to be exposed?
In 2010, on his blog, Randi revealed his gay sexuality.
In 2013, he ‘married’ the Venezuelan artist José
Alvarez. On 20 October 2020, James Randi died in
Florida, aged 92. His central message is as important
for scientists as for everyone else, ‘Don’t be too sure of
yourself. No matter how smart or well educated you are,
you can be deceived.’ In our age of disinformation, we
need individuals like James Randi to keep us ever a little
sceptical and ever prepared to hunt down the truth.
USA and Elsewhere
DJ Trump’s pro-life legacy
Whatever you think of the man, it cannot be denied that Donald
Trump’s four years as President of the USA were marked by
major pro-life gains. There are, according to Katey
Price of the Lozier Institute, at least four:
1] Mexico City policy. This programme, begun under
the Reagan Administration, bars taxpayer funding for
organisations that provide abortion or involuntary
sterilisation overseas. Its renewal was the first
pro-life action of the Trump administration in 2017.
2] Title X of the Public Health Service Act
(PHSA). In 2018, the Trump administration supported
rules affecting Title X family planning programs, which impact
low-income and uninsured Americans, specifically women and
girls. Title X grantees receiving federal funding could
no longer provide or refer for abortions.
3] Appointing judicial nominees. As well as
appointing over 200 judges across the country, Tump appointed
three to the Supreme Court. They were Justices Amy Coney
Barrett, Brett Kavanaugh and Neil Gorsuch. These are
considered to be pro-life and could affect any consideration
of Roe vs. Wade.
4] Recent pro-life actions. In 2020, the Trump
administration took action to protect individuals with
disabilities. In his last week of office the President
issued a draft rule to protect infants born alive with
disabilities.
Joe Biden, though a declared Roman Catholic, is also an ardent
pro-abortionist. With his inauguration as the 46th
President of the USA, it is expected that his administration
will seek to repeal many of the pro-life gains of Trump’s time
in office. For example, on 28 January 2021, President
Biden signed an executive order revoking the Mexico City
policy. He has also called for a review of the Title X
rule. And he wants to dismantle Trump’s proposals that
would have cut taxpayer’s funding of Planned Parenthood by
hundreds of millions of dollars.
Perhaps the one enduring bright spot of the Trump legacy is
that the balance of the Supreme Court now appears to be
decidedly pro-life. Local and federal laws and
regulations imposing the Biden’s administration’s extreme
policies on abortion may yet be struck down.
The March for Life 2021
Every year, on 22 January, pro-life Americans commemorate the
day that Roe vs. Wade legalised
US abortion 48 years ago, by joining in the March for
Life. The event has always centred on Washington DC, but
this year it had to go virtual on 29 January.
This year one of the keynote speakers was former NFL star Tim
Tebow. He encouraged pro-lifers not to lose hope or give
up the fight but to continue advocating for life at all
stages, born and unborn. He continued, ‘You know, I’ve
given so much of my life for sports … but that’s for trophies
that rust …’ ‘But you see, being passionate about Jesus
… and passionate about those that have been thrown away and
neglected and forgotten? That is worthy.’ ‘You
see, when you’re pro-life, I believe that we’re called to be
pro-life in every area – for the unborn, for the hurting, for
the orphan, for the thrown-away, for the special needs, for
the trafficked, for all of humanity.’ He encouraged
pro-lifers to always be pro-life, ‘… all the time, everywhere,
no matter what.’
Is the USA pro-life?
The group, Students for Life of America, recently released
results of a poll conducted during January 2021 among 800
registered voters aged 18 to 34, namely Millennials and Gen Z.
Asked about reversing Roe vs. Wade,
returning the issue of abortion to the individual states, most
Millennials and Gen Z supported the proposal by a margin of 44
% in favour to 36 % opposed with 18 % unsure. These
first two figures changed to 57 % and 30 % when respondents
learned that Roe vs. Wade allows
for abortion through all 9 months. In addition, almost
half (47%) of those questioned supported banning abortion
after a heartbeat was detected.
Also in January, a new nationwide poll, conducted by Marist
College, found that a majority of all-aged Americans are
pro-life and opposed to all or virtually all abortions that
take place in America today. For example, 51% of
Americans self-identified as pro-life. Legal limits on
abortion were supported by 76% of those polled, while 77%
opposed taxpayer funding of abortions. And only 19% of
Americans either ‘support’ or ‘strongly support’ funding
abortions outside the US.
These findings are significant because they are contrary to
President Biden’s and Planned Parenthood’s position that
abortion should be freely available at any time during a
pregnancy, either in the US, or anywhere else.
China’s demographic crisis
Despite its 1.4 billion people, China is experiencing a
population catastrophe. And despite its recent
introduction of a two-child policy, the number of Chinese
registered births continues to fall. Only 10 million
were recorded in 2020, a decrease of 15% compared with
2019. Moreover, the sex ratio of boys to girls was 1.11
to 1 – indicating that sex selection, in favour of boys, is
still occurring.
And all predictions point to a worsening situation. Not
only are the 2020 data the lowest in recent decades, it seems
likely they will be the highest for the next few
decades. China’s current fertility rate is lower than
its replacement rate, meaning the population is shrinking and
bringing with it the problems of an aging citizenship and a
lack of young workers.
Abortion ban in Croatia?
Currently, abortion in Croatia is permitted up to 10 weeks of
a pregnancy and for longer under limited circumstances.
From 1 February, Croatian politicians from the Sovereignist
party have been collecting parliamentary signatures to press
for a discussion of a proposed new Bill, which would protect
life from conception.
Under the Bill, abortion would be permitted only if a mother’s
life were in danger. An additional focus would be on
education, counselling and prevention. The party’s
leader, Hrvoje Zekanović, said, ‘This is a chance for all
those who call themselves Christian Democrats to prove that
they are indeed prepared to protect human life from its
conception.’ The exercise will at least tell the
Croatian people which members of the Sabor are truly pro-life.
Croatia’s current abortion law was adopted in 1978. In
2017, the Constitutional Court ordered parliament to pass a
new law on abortion within two years. The Sovereignists
have been waiting since March 2019 for their proposal to be
put up for parliamentary debate. Maybe 2021 will be
their year.
Abortion ban in Honduras
In late January 2021, the Honduran National Congress
strengthened its pro-life legislation by amending the national
Constitution to declare that unborn children have the same
legal rights as born human beings. The revised
Constitution now reads, ‘The unborn shall be considered as
born for all rights accorded within the limits established by
law. It is prohibited and illegal for the mother or a
third party to practice any form of interruption of life on
the unborn, whose life must be respected from conception.’
Since Argentina legalised abortion last December, there is a
fear that other South American countries would follow
suit. However, Hondurans have been spurred to take
action to create a ‘shield against abortion’ in their
homeland, where most people support unborn babies’ right to
life. Moreover, the Congress of Honduras voted 88 to 28
in favour of legislation that would increase the voting
threshold to 75% in order to repeal the constitutional right
to life of the unborn.